This inventor holds 1 USPTO granted patent. Top assignee: Amgen Inc.. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Mghele Vellah Ncube: Innovator in Pain Treatment Solutions
Introduction
Mghele Vellah Ncube is a notable inventor based in Simi Valley, California. He has made significant contributions to the field of pain management through his innovative research and development. His work focuses on the creation of compounds that target various types of pain, showcasing his commitment to improving patient outcomes.
Latest Patents
Ncube holds a patent for "Vanilloid receptor ligands and their use in treatments." This patent encompasses compounds designed to treat a wide range of conditions, including acute, inflammatory, and neuropathic pain. The applications of his invention extend to dental pain, headaches, arthritis, and various inflammatory disorders. His research aims to address chronic inflammatory conditions and associated pain, providing potential relief for patients suffering from debilitating ailments.
Career Highlights
Ncube is currently employed at Amgen Inc., a leading biotechnology company known for its innovative approaches to healthcare. His role at Amgen allows him to collaborate with other experts in the field and contribute to groundbreaking research. His dedication to advancing medical science is evident in his patent and ongoing projects.
Collaborations
Ncube has worked alongside esteemed colleagues such as Christopher Hulme and Mark Henry Norman. These collaborations have fostered an environment of innovation and shared knowledge, further enhancing the impact of their collective work in the field of pain management.
Conclusion
Mghele Vellah Ncube's contributions to the field of pain treatment through his patented innovations highlight his role as a significant inventor. His work at Amgen Inc. and collaborations with other experts underscore his commitment to advancing medical science and improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
